Christopher Moxham

849 total citations
15 papers, 734 citations indexed

About

Christopher Moxham is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher Moxham has authored 15 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher Moxham's work include Receptor Mechanisms and Signaling (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Blood groups and transfusion (3 papers). Christopher Moxham is often cited by papers focused on Receptor Mechanisms and Signaling (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Blood groups and transfusion (3 papers). Christopher Moxham collaborates with scholars based in United States, Singapore and Japan. Christopher Moxham's co-authors include Vincent Duronio, Steven Jacobs, C C Malbon, Laura Seestaller, Donald Sullivan, Janet Sredy, Alan H. Katz, Diane R. Sawicki, M P Graziano and Michael S. Malamas and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Endocrinology.

In The Last Decade

Christopher Moxham

14 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Moxham United States 9 487 189 153 109 87 15 734
Thomas Buhl Switzerland 18 314 0.6× 80 0.4× 294 1.9× 83 0.8× 78 0.9× 25 879
Rosanna Tedesco United States 13 345 0.7× 151 0.8× 368 2.4× 57 0.5× 25 0.3× 15 1.1k
Esther Y. Chao United States 11 546 1.1× 87 0.5× 132 0.9× 39 0.4× 60 0.7× 15 881
Margaret E. Olson United States 19 384 0.8× 34 0.2× 78 0.5× 55 0.5× 38 0.4× 32 797
Mary Pat Beavers United States 17 408 0.8× 40 0.2× 192 1.3× 55 0.5× 34 0.4× 25 729
C.J. Apolito United States 7 495 1.0× 343 1.8× 29 0.2× 92 0.8× 47 0.5× 8 967
Richard A. Nugent United States 15 289 0.6× 63 0.3× 356 2.3× 20 0.2× 93 1.1× 26 897
David A. Ellis United States 16 207 0.4× 82 0.4× 146 1.0× 69 0.6× 40 0.5× 38 580
Anette Wärnmark Sweden 9 448 0.9× 89 0.5× 32 0.2× 87 0.8× 31 0.4× 11 743
J.C. Faye France 12 263 0.5× 170 0.9× 33 0.2× 78 0.7× 75 0.9× 25 667

Countries citing papers authored by Christopher Moxham

Since Specialization
Citations

This map shows the geographic impact of Christopher Moxham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Moxham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Moxham more than expected).

Fields of papers citing papers by Christopher Moxham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Moxham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Moxham. The network helps show where Christopher Moxham may publish in the future.

Co-authorship network of co-authors of Christopher Moxham

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Moxham. A scholar is included among the top collaborators of Christopher Moxham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Moxham. Christopher Moxham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Xie, Keqiang, Mark J. Roth, Ivan Efremov, et al.. (2021). Ftx-6058 Induces Fetal Hemoglobin Production and Ameliorates Disease Pathology in Sickle Cell Mice. Blood. 138(Supplement 1). 2018–2018. 6 indexed citations
3.
Xie, Keqiang, Mark J. Roth, Ivan Efremov, et al.. (2020). In Vivo Characterization of Ftx-6058, a Novel Small Molecular Fetal Hemoglobin Inducer for Sickle Cell Disease. Blood. 136(Supplement 1). 26–27. 3 indexed citations
4.
Rahl, Peter B., et al.. (2020). In Vitro Characterization of FTX6058, a Novel Small Molecule Fetal Hemoglobin Inducer for Sickle Cell Disease. Blood. 136(Supplement 1). 12–12. 1 indexed citations
5.
Lim, Seng Gee, Nancy Leung, Hie‐Won Hann, et al.. (2008). Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti‐viral activity of clevudine for 12 weeks in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 27(12). 1282–1292. 19 indexed citations
6.
Regmi, Ajit, et al.. (2005). Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation. Bone. 36(2). 284–291. 8 indexed citations
7.
Szczech, George M., P A Furman, George R. Painter, et al.. (2000). Safety Assessment, In Vitro and In Vivo, and Pharmacokinetics of Emivirine, a Potent and Selective Nonnucleoside Reverse Transcriptase Inhibitor of Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 44(1). 123–130. 40 indexed citations
8.
Malamas, Michael S., Janet Sredy, Christopher Moxham, et al.. (2000). Novel Benzofuran and Benzothiophene Biphenyls as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties. Journal of Medicinal Chemistry. 43(7). 1293–1310. 188 indexed citations
9.
Wrobel, Jay, Janet Sredy, Christopher Moxham, et al.. (1999). PTP1B Inhibition and Antihyperglycemic Activity in the ob/ob Mouse Model of Novel 11-Arylbenzo[b]naphtho[2,3-d]furans and 11-Arylbenzo[b]naphtho[2,3-d]thiophenes. Journal of Medicinal Chemistry. 42(17). 3199–3202. 107 indexed citations
10.
Furman, P A & Christopher Moxham. (1998). MKC-442. Drugs of the Future. 23(7). 718–718. 1 indexed citations
11.
Yamamoto, Kazutoshi, E G Lapetina, & Christopher Moxham. (1992). Insulin like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor.. Endocrinology. 130(3). 1490–1498. 34 indexed citations
12.
Moxham, Christopher, Vincent Duronio, & Steven Jacobs. (1989). Insulin-like Growth Factor I Receptor β-Subunit Heterogeneity. Journal of Biological Chemistry. 264(22). 13238–13244. 220 indexed citations
13.
Moxham, Christopher, et al.. (1988). Beta-adrenergic receptors display intramolecular disulfide bridges in situ: analysis by immunoblotting and functional reconstitution.. Molecular Pharmacology. 33(5). 486–492. 24 indexed citations
14.
Moxham, Christopher, Shaji T. George, M P Graziano, Harvey Brandwein, & C C Malbon. (1986). Mammalian beta 1- and beta 2-adrenergic receptors. Immunological and structural comparisons.. Journal of Biological Chemistry. 261(31). 14562–14570. 49 indexed citations
15.
Graziano, M P, Christopher Moxham, & C C Malbon. (1985). Purified rat hepatic beta 2-adrenergic receptor. Structural similarities to the rat fat cell beta 1-adrenergic receptor.. Journal of Biological Chemistry. 260(12). 7665–7674. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026